Home Page >
Site Map_
About ProStrakan
- Strategy
- Who's Who
+ Board Members
+ Executive Commitee
- Press Releases
Our Products
- Belgium
- Denmark
- Finland
- France
- Portugal
- Spain
- Sweden
- United Kingdom
- Germany
- Greece
- The Netherlands
Investor Relations
- Share Price Information
+ Share Price Graph
- Annual Report
- AGM
- Product Table
- Press Releases
- Latest Developments
- Glossary
- FAQs
- Who's Who
+ Board Members
+ Executive Committee
- Corporate Presentations
- Corporate Governance
Media Centre
- Press Releases
+ Archive of Press Releases
- Latest Developments
Search Results Page
- Search Results - No Results
- Search Results - Syntax Error
Research and Development
- Development Projects
+ Trim Patch
+ Topical Anti-Androgen
+ Anti-Emetic
+ Topical Nitric Oxide
+ Male HRT
+ Drug Conjugates
Patient Information
- Women's Health
+ Osteoporosis
+ Pre-eclampsia
+ HRT
- Men's Health
- Metabolic Diseases
+ Osteoporosis
- Dermatology
+ Onychomycosis
- Cancer
+ Acute Myeloid Leukaemia
+ Ovarian Cancer
+ Glioblastoma
+ Medulloblastoma
+ Emesis
- Anaesthesiology
+ Post Operative Nausea and Vomiting
+ Patient Controlled Analgesia
- Cardiovascular Diseases
+ Angina
+ Acute Hypertensive Crisis
- Psychiatric Disease
